Dr. Sertil's primary interest is in cancer research. Dr. Sertil joined the faculty of BMS as an Assistant Professor in 2010. She received her PhD in 2002 in Biochemistry and Molecular Biology from Albany Medical College in Albany, New York, where she investigated the effects of reactive oxygen species in gene regulation in tumor cells. She completed her postdoctoral training at the State University of New York – Albany. During her tenure, she received the NRSA postdoctoral fellowship from NIH to identify the molecular mechanisms involved in tumor dormancy and drug resistance. Her studies identified ER stress response as one of the regulators of dormancy and drug resistance in dormant tumor cells. Following her training, she joined Mount Sinai School of Medicine in New York City as a Research Assistant Professor in 2008. Combining her interest in oxidative stress and ER stress response, she set out to examine the role of ER stress program in hypoxia induce therapy resistance in head and neck cancer. This study is funded by the New Investigator award (R03) from NIDCR.